Mr Carl Gibson, Chief Executive Officer of Complementary Medicines Australia (CMA), presenting to the NSW Committee of the Healthcare Complaints Commission (HCCC) today, queried the rationality of the Inquiry into ‘The promotion of false or misleading health-related information or practices’.

Read the alert here